[BREAKING] [Exclusive] Kookjeon Pharmaceutical's "Upper Price" contract for the development of COVID-19 treatment worth 130.3 billion won. Supply to the U.S. Defense.

23 October Share

[BREAKING] [Exclusive] Kookjeon Pharmaceutical's "Upper Price" contract for the development of COVID-19 treatment worth 130.3 billion won. Supply to the U.S. Defense.

国電薬品「ストップ高」、1303億ウォンのコロナ19治療剤開発契約。 米国防総省に供給

[独家]国电药品"上限价"，1303亿韩元 新型冠状病毒治疗剂开发合同... 美国国防供应

[Только] Контракт на разработку национальных лекарственных препаратов "Sanghanga", 130,3 млрд. вон. 美Поставка в оборону США

[단독] 국전약품 ‘상한가’, 1303억원 코로나19 치료제 개발 계약.. 美국방에 공급 [More News]